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Diabetes is the most common metabolic causes of increased mortality rate due to 
multiple complications of this disease. Diabetes, thus, influences patients’ quality of life 
due to its resultant physical disabilities and mental health problems. This study aimed 
to investigate health-related quality of life among Iranian patients with type 2 diabetes. 
In this meta-analysis study, a search was conducted with the keywords Quality of Life, 
Health-Related Quality of Life, QoL, HRQoL, Shortform questionnaire 36, SF-36, 
Diabetes and Iran in the national and international databases such as SID, MagIran, 
ISI/Web of Science, PubMed [including Medline], and Scopus between 2011 and 2018. 
Based on the heterogeneity of data, the random effects model was used. Data was 
analyzed using the Stata software version 14. Overall, 17 studies were eligible, with a 
total sample size of 5472 patients, showed that the mean score of the physical dimension 
in patients with type 2 diabetes (53.5, 95% CI: 43.1-63.9) was less than the mean of 
mental dimension score (54.5, 95% CI: 47-61.9). By increasing the age of samples, the 
mean of the HRQoL score of the Iranian patients with type 2 diabetes was significantly 
decreased (p = 0.015). The highest and lowest scores for the quality of life subscales 
were social function and general health, respectively. Patients with type 2 diabetes have 
a moderate quality of life. Providing solutions to improve the quality of life of this group 
of patients especially in the physical aspect is required. 





Diabetes is the most common metabolic and epidemic disease of the third millennium, 
which has been shown to reduce the life expectancy of patients (1, 2). Due to its 
similarity to the plague epidemic in the 14th century in terms of morbidity and mortality, 
diabetes is also known as the plague of the 21st century (3). Due to its microvascular 
complications including retinopathy, nephropathy, neuropathy and macrovascular 
diseases such as cardiovascular, cerebrovascular and stroke, the mortality rate for 
diabetic patients is twice than that for non-diabetic patients (4). According to reports in 
2005, the prevalence of diabetes in Iran was 7.7% (equivalent to 2 million people), and 
is projected to increase to 5 million people by 2025 (5). Every patient with diabetes has 
a unique life career. While many patients cannot effectively control their illness, it is 
believed that diabetes has a huge impact on patients’ health condition (6). Diabetes can 
lead to a reduction in patients’ health-related quality of life (7).  
The quality of life refers to the individual’s point of view about the difference between 
what is and what should be (8). Food constraints and inconsistencies in social roles, 
psychosocial problems, and continuous maintenance of self-management behaviors 
have significant effects on the quality of life of these patients (9, 10). In the study of 
Wandell et al. (2005), macrovascular complications (especially cardiovascular disease) 
were the strongest predictors of the quality of life of patients with diabetes (11). 
Quality of life (QoL) is often measured by self-reported instruments, including  SF-36 
which has two main physical and mental dimensions, and each of these dimensions has 
been consisted of 4 sub-scales. Physical dimension of quality of life includes four 
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subscales of physical function, physical activity limitation, physical and general health. 
The psychological dimension includes subscales of vitality, social function, mental role 
retardation and mental health (12). Contrary to some quality of life instruments that are 
limited to a specific group and are always criticized for such a limitation, the SF-36 
instrument is a general tool and can measure all important aspects of patient health. This 
instrument can compare similar patients or patients with various conditions and diseases 
(13). This questionnaire was translated and revised by Montazeri et al. (2005) (14). 
Accordingly, the purpose of this study was to estimate HRQoL among Iranian patients 
with type 2 diabetes using the SE-36 instrument. The study findings could be useful for 
policy-makers and decision-makers to improve their knowledge of quality of life and 
provide a background for evidence-based decision making. 
2. Methodology 
2.1. Search strategy 
In this systematic review and meta-analysis, the PRISMA guideline was used to review 
health -related quality of life (HRQoL) of Iranian patients with type 2 diabetes (15). 
Two independent researchers reviewed the national and international scientific 
information databases including Scientific Information Database (SID), MagIran, 
Google Scholar, ISI / Web of Science, PubMed [including Medline], and Scopus 
between 2011 and 2018. In the study of Kiadaliri et al. (2013), the quality of life of 
patients with diabetes was assessed and reported until year 2011 (4). The references’ 
list of the reviewed articles were also assessed to improve coverage. The QoL, HRQoL, 
Shortform questionnaire 36, SF-36, Diabetes, Iran, the Quality of Life, Health-Related 
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Quality of Life, and the combination of these terms were used to search strategy in the 
PubMed database as follows: ("Quality of Life"[All Fields] OR "Health-Related Quality of 
Life"[All Fields] OR "QOL"[All Fields] OR "HRQoL"[All Fields]) AND ((Shortform[All 
Fields] AND ("surveys and questionnaires"[MeSH Terms] OR ("surveys"[All Fields] AND 
"questionnaires"[All Fields]) OR "surveys and questionnaires"[All Fields] OR 
"questionnaire"[All Fields]) AND 36[All Fields]) OR "SF-36"[All Fields]) AND 
"Diabetes"[All Fields] AND "Iran"[All Fields]. 
2.2. Selection of studies and data extraction 
First, all the articles referred to the quality of life of patients with type 2 diabetes were 
collected. Inclusion criteria were: observational (non-interventional) studies, published 
in Farsi or English languages, studying exclusively on patients with type 2 diabetes, 
assessing the health related quality of life using the SF-36 questionnaire, and providing 
adequate information related to the research objectives. Exclusion criteria included non-
relevance to the study topic, inadequate data, repeated studies, research on the 
combination of both types of patients with diabetic type 1 and type 2, and lack of access 
to the full text of articles. Accordingly, the abstracts of the articles were examined by 
the researchers and the relevant ones were selected. A checklist was used to extract data 
on the author of the first article, the year of publication, place of the study, sample size, 
place of the research, scores of the eight subscales and two main dimensions of quality 
of life and the overall score of the quality of life. Each article was studied independently 
by two researchers, and, in case of controversy, the article was judged by another author 
who was expert in the field of meta-analysis. 
2.3. Review of the methodological quality of the articles 
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The methodological quality of the articles was evaluated using a tool applied in various 
Iranian and foreign studies. This tool included 5 items of the study plan, comparison 
group, description of the characteristics of samples, sample size, and tool used, each 
item was scored from 0 to 3, with a higher score indicating a higher methodological 
quality. Accordingly, the articles were categorized into three categories of weak (score 
0-5), moderate (6-10), and strong (scores above 10) in terms of methodological quality 
(16-18). Some of these studies did not report the mean score of the main physical and 
mental dimensions of the quality of life, and some did not report the mean score of eight 
subscales, so only articles with sufficient and adequate data was included in data 
analysis. 
2.4. Statistical analysis 
Since the quality of life score had a normal distribution, the variance of each research 
was calculated using the variance of normal distribution as follow: Var (x) = σ2/n. The 
weight assigned to each study was proportional to the variance. The mean score of the 
quality of life related to health and its dimensions was estimated at a 95% confidence 
interval. To analyze the heterogeneity of the data, I2 and Q-Cochran test were used. If 
the I2 index was more than 50% or the probability of the Q-Cochran test was less than 
0.05 (p<0.05), the random effect model was used and otherwise the fixed-effect model 
was used for estimating the scores of the quality of life. To study the association 
between physical and mental dimensions of the quality of life with mean age, year of 
the study, sample size and mean scores of methodological quality of studies, a meta-
regression model was used. The probability of bias in the publication of study was 
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investigated using the Begg's funnel plot. Data analysis was performed via the Stata 
software version 14 and the significance level was set as p<0.05. 
3. Results 
The initial search retrived 534 articles, of which 446  were excluded due to a lack of 
relevance to the subject. Of the remaining 88 articles, 17 articles were selected for data 
analysis (Figure 1). 
 




The largest and lowest sample sizes were in the studies by Gholami (n=1847) and 
Aghakoochak (n=50), respectively. Furthermore, nine articles were published in 
English and eight  in Farsi (Table 1). 
Table 1: Table 1. Characteristics of the eligible articles 




Year First Author N 
6 Urmia 182 - 250 2017 Zareipour (19) 1 
8 Sabzevar 152 56.7±1.02 197 2017 Karimi moghadam (10) 2 
6 Neyshabur 1289 59.6±12.3 1847 2017 Gholami (20) 3 
10 Zanjan - - 80 2017 Ebrahimi (21) 4 
8 Kerman 69 71.3±5.1 120 2016 Borhaninezhad (22) 5 
9 Babol 375 - 747 2016 Hajian (23) 6 
11 Larestan 89 51.5±11.4 124 2015 Kashfi (24) 7 
8 Ahvaz 51 53.4±8.1 110 2015 Mohammadshahi (25) 8 
7 Yazd 25 55.3±14.2 50 2014 Aghakoochak(26) 9 
6 Qazvin 66 47±9.3 114 2014 Ghorbani (27) 10 
7 Qazvin 576 - 1103 2013 Ghorbani (28) 11 
9 Tabriz 30 - 60 2013 Hatamloo (29) 12 
4 Tehran 38 49.1±12.5 120 2012 Kazemi-Galougahi (30) 13 
9 Tehran 81 52.8±7.4 125 2012 Arian (31) 14 
10 Mash-had 54 42.8±16.5 100 2012 Saadatjoo (32) 15 
7 Hamadan 111 - 165 2011 Borzou (33) 16 




The 17 eligible articles had a sample size of 5472 patients, with a mean of 322 patients. 
The mean of physical score for patients with type 2 diabetes (53.5%, 95% CI: 43.1-
63.9) was lower than the mental score (54.5%, 95% CI: 47-61.9).  
 
 
Figure 2: Mean scores on the physical (A) and Mental (B) dimension of HRQoL for patients with 
Diabetes type II. CI of 95% for each article is represented as horizontal lines near the main mean line; 
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dashed line at the mid represents an estimate of the total mean score; and the rhomboid represents CI 
of the mean HRQOL score 
 
The highest and lowest mean scores for the quality of life subscales were for social 
functioning (64.3%) and general health (47.6%), respectively. The mean scores of all 
subscales of the quality of life were reported in Table 2 and Figure 3.  








Down Up I2 Q P 
Physical 
Domain 
PF 62.2 55.5 68.9 98.9 1358.8 0.001 
RP 52.9 46.8 59 97.6 620.8 0.001 
BP 55.3 52.2 58.4 97.1 484.7 0.001 
GH 47.6 42.8 52.3 98.9 1341 0.001 
Mental  
Domain 
VI 49.3 45.4 53.2 98.3 884.7 0.001 
SF 64.3 58.7 70 98.9 1405.6 0.001 
RE 54.7 49.8 59.7 96.5 434.4 0.001 
MH 53.4 49.7 57.1 98.4 919.6 0.001 
Abbreviations: RP, role limitations; PF, physical functioning; BP, bodily pain; GH, general health; VI, Vitality; 





Figure 3: Combined mean for the eight HRQoL subscales extracted using the SF-36 in patients with 
Diabetes Type II. 
 
The results of metaregression showed no relationship between the year of publication 
of the articles (p = 0.404), sample size (p = 0.671) and the methodological quality of 
articles (p = 0.835) with mean of the HRQoL score for patients with type 2 diabetes. 
However, by increasing the age of samples, the mean of the HRQoL score of the Iranian 




Figure 4. The meta-regression of the relationship between the mean age of patients with the overall 
quality of life in patients with type 2 diabetes 
The results also showed that the selection bias was not statistically significant 
(p=0.251). 
 






Health-related quality of life is a multidimensional concept that focuses on the impact 
of illness and treatment on patients, and it can measure patients’ perceptions of illness 
and treatment, their perceived needs for healthcare providers and their preferences for 
treatment and outcomes of the disease (35). This study aimed to estimate the mean 
scores of quality of life in Iranian patients with type 2 diabetes and its dimensions and 
showed that the mean scores of physical dimension and mental dimension were 53.5 
and 54.5, respectively. Since the standard of quality of life of this group of patients in 
our society has not been determined, the mean of 50 with a standard deviation of 10 
could be considered acceptable indices. Accordingly, the quality of life of Iranian 
patients with type 2 diabetes was reported as moderate (8). The results of this study 
showed that the mean score of the physical dimension of the quality of life of these 
patients was lower than the mean score of their mental health. In other words, diabetes  
impacted patients’ physical aspect of the quality of life more than the mental dimension. 
This finding was consistent with the results of studies conducted in Canada and the 
Netherlands (36, 37). The results of study by Kuznetsov et al. on patients with type 2 
diabetes in the three countries of the Netherlands, Denmark and the United Kingdom, 
showed that the mean score of physical dimension of the patients was less than the mean 
score of their mental dimension (38). Other studies also suggested that physical 
problems, such as diabetic foot ulcers, led to a reduction of the quality of life especially 
in the physical aspect due to decreased mobility and independence of the patients (39-
41).  
The highest and lowest mean scores for the quality of life subscales were social function 
(64.3%) and general health (47.6%), respectively, which were consistent with the 
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results of the study by Hermann et al. (1996) (42). The results of a study in Greece 
showed that the highest and lowest HRQoL scores for diabetic patients were related to 
physical function and general health subscales (43). Physical and mental health 
problems caused by diabetes have less effect on the social function of patients. The 
results of this study showed that with increasing patients’ age, their quality of life 
significantly decreased. Various studies have supported this finding. For instance,  in 
the study by Lindsay et al. (2011), the quality of life score declined with age (44). In 
Glasgow et al.’s study, younger patients had a better quality of life (45). The results of 
Trief et al.’s study showed that older people had more problems and lower quality of 
life than younger people (46). As the age increases, the risk of developing other diseases 
and the complications of diabetes will also increase. Therefore, the quality of life of 
patients with type 2 diabetes is expected to decrease as their age increases. The strength 
of this study was that it provided up-to-date and comprehensive outcome on health-
related quality of life in Iranian patients with type II diabetes.  
5. Conclusion 
The results of this study can be used by policy makers and healthcare managers in order 
to provide strategies to improve the quality of life in patients with type 2 diabetes 
especially in the physical aspect. 
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